204 related articles for article (PubMed ID: 34948208)
1. The Small-Molecule Wnt Inhibitor ICG-001 Efficiently Inhibits Colorectal Cancer Stemness and Metastasis by Suppressing MEIS1 Expression.
Choi JH; Jang TY; Jeon SE; Kim JH; Lee CJ; Yun HJ; Jung JY; Park SY; Nam JS
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948208
[TBL] [Abstract][Full Text] [Related]
2. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
Ayadi M; Bouygues A; Ouaret D; Ferrand N; Chouaib S; Thiery JP; Muchardt C; Sabbah M; Larsen AK
Oncotarget; 2015 Jul; 6(21):18518-33. PubMed ID: 26041882
[TBL] [Abstract][Full Text] [Related]
3. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner.
Wiese M; Walther N; Diederichs C; Schill F; Monecke S; Salinas G; Sturm D; Pfister SM; Dressel R; Johnsen SA; Kramm CM
Oncotarget; 2017 Apr; 8(16):27300-27313. PubMed ID: 28460484
[TBL] [Abstract][Full Text] [Related]
4. Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer.
Kartha VK; Alamoud KA; Sadykov K; Nguyen BC; Laroche F; Feng H; Lee J; Pai SI; Varelas X; Egloff AM; Snyder-Cappione JE; Belkina AC; Bais MV; Monti S; Kukuruzinska MA
Genome Med; 2018 Jul; 10(1):54. PubMed ID: 30029671
[TBL] [Abstract][Full Text] [Related]
5. 5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation.
Cho YH; Ro EJ; Yoon JS; Mizutani T; Kang DW; Park JC; Il Kim T; Clevers H; Choi KY
Nat Commun; 2020 Oct; 11(1):5321. PubMed ID: 33087710
[TBL] [Abstract][Full Text] [Related]
6. Aberrant activation of the CD45-Wnt signaling axis promotes stemness and therapy resistance in colorectal cancer cells.
Park SY; Kim JY; Jang GB; Choi JH; Kim JH; Lee CJ; Lee S; Baek JH; Park KK; Kim JM; Chang HJ; Cho NC; Nam JS
Theranostics; 2021; 11(18):8755-8770. PubMed ID: 34522210
[No Abstract] [Full Text] [Related]
7. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
8. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
[TBL] [Abstract][Full Text] [Related]
9. A Novel Small-molecule WNT Inhibitor, IC-2, Has the Potential to Suppress Liver Cancer Stem Cells.
Seto K; Sakabe T; Itaba N; Azumi J; Oka H; Morimoto M; Umekita Y; Shiota G
Anticancer Res; 2017 Jul; 37(7):3569-3579. PubMed ID: 28668848
[TBL] [Abstract][Full Text] [Related]
10. JIB-04, A Small Molecule Histone Demethylase Inhibitor, Selectively Targets Colorectal Cancer Stem Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway.
Kim MS; Cho HI; Yoon HJ; Ahn YH; Park EJ; Jin YH; Jang YK
Sci Rep; 2018 Apr; 8(1):6611. PubMed ID: 29700375
[TBL] [Abstract][Full Text] [Related]
11. WNT/β-Catenin Signaling Inhibitor IC-2 Suppresses Sphere Formation and Sensitizes Colorectal Cancer Cells to 5-Fluorouracil.
Urushibara S; Tsubota T; Asai R; Azumi J; Ashida K; Fujiwara Y; Shiota G
Anticancer Res; 2017 Aug; 37(8):4085-4091. PubMed ID: 28739692
[TBL] [Abstract][Full Text] [Related]
12. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X
Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922
[TBL] [Abstract][Full Text] [Related]
13. Small-molecule inhibition of CBP/catenin interactions eliminates drug-resistant clones in acute lymphoblastic leukemia.
Gang EJ; Hsieh YT; Pham J; Zhao Y; Nguyen C; Huantes S; Park E; Naing K; Klemm L; Swaminathan S; Conway EM; Pelus LM; Crispino J; Mullighan CG; McMillan M; Müschen M; Kahn M; Kim YM
Oncogene; 2014 Apr; 33(17):2169-78. PubMed ID: 23728349
[TBL] [Abstract][Full Text] [Related]
14. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N
Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
16. Selective AKT Inhibition by MK-2206 Represses Colorectal Cancer-Initiating Stem Cells.
Malkomes P; Lunger I; Luetticke A; Oppermann E; Haetscher N; Serve H; Holzer K; Bechstein WO; Rieger MA
Ann Surg Oncol; 2016 Sep; 23(9):2849-57. PubMed ID: 27059026
[TBL] [Abstract][Full Text] [Related]
17. Canonical Wnt pathway inhibitor ICG-001 induces cytotoxicity of multiple myeloma cells in Wnt-independent manner.
Grigson ER; Ozerova M; Pisklakova A; Liu H; Sullivan DM; Nefedova Y
PLoS One; 2015; 10(1):e0117693. PubMed ID: 25635944
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-Specific Peptidase 22 Contributes to Colorectal Cancer Stemness and Chemoresistance via Wnt/β-Catenin Pathway.
Jiang S; Song C; Gu X; Wang M; Miao D; Lv J; Liu Y
Cell Physiol Biochem; 2018; 46(4):1412-1422. PubMed ID: 29689565
[TBL] [Abstract][Full Text] [Related]
19. MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma.
Zargari S; Negahban Khameneh S; Rad A; Forghanifard MM
BMC Cancer; 2020 Aug; 20(1):789. PubMed ID: 32819319
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
Prabhu VV; Lulla AR; Madhukar NS; Ralff MD; Zhao D; Kline CLB; Van den Heuvel APJ; Lev A; Garnett MJ; McDermott U; Benes CH; Batchelor TT; Chi AS; Elemento O; Allen JE; El-Deiry WS
PLoS One; 2017; 12(8):e0180541. PubMed ID: 28767654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
